# Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib

> **NCT01343173** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 220 (estimated)

## Conditions studied

- Chronic Myeloid Leukaemia

## Interventions

- **DRUG:** Imatinib stop

## Key facts

- **NCT ID:** NCT01343173
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-06
- **Primary completion:** 2017-05-30
- **Final completion:** 2017-05-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01343173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01343173, "Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01343173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*